Ceribell Inc., based in Sunnyvale, California, has developed a point-of-care EEG system that provides real-time seizure monitoring and alerting, which helps in the rapid and precise treatment of patients with suspected non-convulsive seizures. The FDA-cleared Ceribell ClarityPro software uses a machine-learning model to analyze EEG signals and generate bedside alerts.
The FDA approved the cannabis-based drug for treating seizures in two severe forms of epilepsy.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
By passively collecting seizure data, Empatica's device could help patients share medical information with clinicians and make that data easier to manage.
It’s easier to help a person having an epileptic seizure in the well-lit daytime as opposed to the pitch-black night. That’s the problem the SAMi monitor is changing. SAMi founders Cynthia and Charles Anderson created the device to help monitor the seizures their son was having at night. Charles, who is an engineer, developed the […]